"Type 2 Diabetes Therapeutics Market to 2019 - a Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019" Now Available at Fast Market Research
GBI Research has released its latest report for the pharmaceuticals industry, "Type 2 Diabetes Therapeutics Market to 2019 - A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019". There is currently a large number of blood glucose-lowering drugs in the crowded type 2 diabetes market indicated for the treatment of chronically high blood glucose. The market is led by Lantus, which achieved global sales amounting to $6.4 billion in 2012. Over the forecast period from 2012...
View full press release